News

Neurizon’s ALS drug shows safety and extended survival in open-label extension study

Neurizon Therapeutics has reported positive topline results from an open-label extension (OLE) study of its lead candidate ...
News-Medical.Net on MSN4h

Researchers gain better understanding of how nerve cells can be protected against ALS

By analyzing millions of messenger RNA molecules (mRNA) during the course of ALS, researchers at Stockholm University, in collaboration with scientists at the Paris Brain Institute and Örebro ...

Surprising gene activity shields certain nerve cells from ALS damage

By analyzing millions of messenger RNA molecules (mRNA) during the course of ALS, researchers at Stockholm University, in ...
ALS News Today9h

Healthy volunteer study’s results net clinical trial for ALS therapy

The ALS therapy ATH-1105 entered the brain and spinal cord at dose-proportional levels in healthy volunteers, and had a good ...
Frontiers10h

Molecular and Cellular Pathways Underlying Neurodegenerative Disorders

Neurodegenerative disorders, including Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, and amyotrophic lateral sclerosis, are among the most ...
Ansa on MSN15h

Italo-US team in ALS diagnosis breakthrough

ROME, AUG 19 - An Italo-US team of scientists have made a breakthrough in the early diagnosis of amyotrophic lateral ...